Abstract
Intravesical chemotherapy is commonly used for the treatment of cr. There is evidence of significant local adverse effects including contact dermatitis and symptoms of bladder overactivity. Doxorubicin has been shown to increase Ach and PGE2 release in human urothelial cells (Chess-Williams et al, 2012). Effects of mitomycin C (MMC) have not been investigated despite evidence of greater toxicity.
Original language | English |
---|---|
Pages | 206-206 |
Number of pages | 1 |
Publication status | Published - 2012 |
Event | Joint ASCEPT- APSA 2012 Conference : Medication Safety - Sydney Convention and Exhibition Centre, Sydney, Australia Duration: 2 Dec 2012 → 5 Dec 2012 http://www.ascept-apsa.com/ |
Conference
Conference | Joint ASCEPT- APSA 2012 Conference |
---|---|
Country/Territory | Australia |
City | Sydney |
Period | 2/12/12 → 5/12/12 |
Internet address |
Fingerprint
Dive into the research topics of 'Mitomycin C alters urothelial ATP, acetylcholine and PGE2 release in vitro'. Together they form a unique fingerprint.Student theses
-
Cytotoxic Drugs and their Effects on Bladder Function
Author: Kang, S. H., 10 Oct 2015Supervisor: McDermott, C. (Supervisor) & Chess-Williams, R. G. (Supervisor)
Student thesis: Doctoral Thesis
File